The Company is required to present basic earnings per share and diluted earnings per share ("EPS") in its Consolidated Statements of Operations. Basic EPS amounts are computed by dividing net income by the weighted average number of shares of common stock outstanding. Diluted EPS reflects additional shares of common stock that would have been outstanding if potentially dilutive shares of common stock had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential shares of common stock that may be issued by the Company relate to outstanding unvested RSAs and RSUs granted to directors and employees, and stock options. The dilutive effect resulting from these potential shares is determined using the treasury stock method. The Company is also required to provide a reconciliation of the numerator and denominator used in the computation of both basic and diluted EPS.


(Net income (loss) in thousands)	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Basic income (loss) per share:
Net income (loss) attributable to Common shareholders	$	143		$	(5,001)		$	(1,612)		$	(7,778)
Divided by:
Weighted average shares outstanding	117,479,316			78,123,095			117,283,603			45,885,468

Basic income (loss) per share of common stock	$	0.00		$	(0.06)		$	(0.01)		$	(0.17)

Diluted income (loss) per share:
Net income (loss) attributable to Common shareholders	$	143		$	(5,001)		$	(1,612)		$	(7,778)

Weighted average shares outstanding	117,479,316			78,123,095			117,283,603			45,885,468

Effect of potentially dilutive restricted shares of common stock	—		(1)	—		(2)	—		(3)	—		(4)

Divided by:
Weighted average diluted shares outstanding	117,479,316			78,123,095			117,283,603			45,885,468

Diluted income (loss) per share of common stock	$	0.00		$	(0.06)		$	(0.01)		$	(0.17)


(1)			The weighted average diluted shares outstanding does not include 887,433 anti-dilutive restricted shares of common stock for the three months ended June 30, 2026.
(2)			The weighted average diluted shares outstanding does not include 4,597,710 anti-dilutive restricted shares of common stock for the three months ended June 30, 2025.
(3)			The weighted average diluted shares outstanding does not include 1,315,833 anti-dilutive restricted shares of common stock for the six months ended June 30, 2026.
(4)			The weighted average diluted shares outstanding does not include 5,119,740 anti-dilutive restricted shares of common stock for the six months ended June 30, 2025.